Synopsis
Synopsis
0
USDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Glycerolphosphate
2. Glycerolphosphates
3. Glycerophosphate
4. Glycerophosphate, Calcium
5. Glycerophosphates
1. 27214-00-2
2. Calcium 2,3-dihydroxypropyl Phosphate
3. 1336-00-1
4. Calcium 1-glycerophosphate
5. 126-95-4
6. Calcium Glycerol Phosphate
7. Calcium;2,3-dihydroxypropyl Phosphate
8. Q014u50xqh
9. 1,2,3-propanetriol, 1-(dihydrogen Phosphate), Calcium Salt (1:1)
10. 1,2,3-propanetriol, Mono(dihydrogen Phosphate), Calcium Salt (1:1)
11. 28917-82-0
12. Unii-q014u50xqh
13. Calcium Glycerinophosphate
14. 2,3-dihydroxypropyl (dihydrogen Phosphate), Calcium Salt
15. Calcium 2,3-hydroxypropyl Phosphate
16. Einecs 204-813-3
17. Einecs 215-643-4
18. Mfcd00042643
19. Schembl4237
20. Chembl2106124
21. Dtxsid40873179
22. Calcium2,3-dihydroxypropylphosphate
23. Cs-b1784
24. Hy-b2203
25. Einecs 249-312-0
26. Akos015962876
27. Ac-2077
28. Calcium Rac-glyceryl-1-phosphate
29. Ft-0700768
30. Ft-0775133
31. Rac-glycero-1-phosphate, Calcium Salt
32. J-006411
33. J-017324
34. Q27286832
35. 4-amino-alpha-diethylamino-o-cresoldihydrochloride
Molecular Weight | 210.14 g/mol |
---|---|
Molecular Formula | C3H7CaO6P |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 3 |
Exact Mass | 209.9606158 g/mol |
Monoisotopic Mass | 209.9606158 g/mol |
Topological Polar Surface Area | 113 Ų |
Heavy Atom Count | 11 |
Formal Charge | 0 |
Complexity | 117 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
ABOUT THIS PAGE
A Calcium Glycerophosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Calcium Glycerophosphate, including repackagers and relabelers. The FDA regulates Calcium Glycerophosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Calcium Glycerophosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Calcium Glycerophosphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Calcium Glycerophosphate supplier is an individual or a company that provides Calcium Glycerophosphate active pharmaceutical ingredient (API) or Calcium Glycerophosphate finished formulations upon request. The Calcium Glycerophosphate suppliers may include Calcium Glycerophosphate API manufacturers, exporters, distributors and traders.
click here to find a list of Calcium Glycerophosphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Calcium Glycerophosphate Drug Master File in Japan (Calcium Glycerophosphate JDMF) empowers Calcium Glycerophosphate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Calcium Glycerophosphate JDMF during the approval evaluation for pharmaceutical products. At the time of Calcium Glycerophosphate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Calcium Glycerophosphate suppliers with JDMF on PharmaCompass.
A Calcium Glycerophosphate CEP of the European Pharmacopoeia monograph is often referred to as a Calcium Glycerophosphate Certificate of Suitability (COS). The purpose of a Calcium Glycerophosphate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Calcium Glycerophosphate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Calcium Glycerophosphate to their clients by showing that a Calcium Glycerophosphate CEP has been issued for it. The manufacturer submits a Calcium Glycerophosphate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Calcium Glycerophosphate CEP holder for the record. Additionally, the data presented in the Calcium Glycerophosphate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Calcium Glycerophosphate DMF.
A Calcium Glycerophosphate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Calcium Glycerophosphate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Calcium Glycerophosphate suppliers with CEP (COS) on PharmaCompass.
A Calcium Glycerophosphate written confirmation (Calcium Glycerophosphate WC) is an official document issued by a regulatory agency to a Calcium Glycerophosphate manufacturer, verifying that the manufacturing facility of a Calcium Glycerophosphate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Calcium Glycerophosphate APIs or Calcium Glycerophosphate finished pharmaceutical products to another nation, regulatory agencies frequently require a Calcium Glycerophosphate WC (written confirmation) as part of the regulatory process.
click here to find a list of Calcium Glycerophosphate suppliers with Written Confirmation (WC) on PharmaCompass.
Calcium Glycerophosphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Calcium Glycerophosphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Calcium Glycerophosphate GMP manufacturer or Calcium Glycerophosphate GMP API supplier for your needs.
A Calcium Glycerophosphate CoA (Certificate of Analysis) is a formal document that attests to Calcium Glycerophosphate's compliance with Calcium Glycerophosphate specifications and serves as a tool for batch-level quality control.
Calcium Glycerophosphate CoA mostly includes findings from lab analyses of a specific batch. For each Calcium Glycerophosphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Calcium Glycerophosphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Calcium Glycerophosphate EP), Calcium Glycerophosphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Calcium Glycerophosphate USP).
LOOKING FOR A SUPPLIER?